Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan N Frone

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|December 17, 2019
Stomaching Multigene Panel Testing: What to Do About CDH1?Douglas R Stewart, Megan N Frone, Stephen J Chanock
JCO Precision Oncology|November 22, 2021
Quantification of Discordant Variant Interpretations in a Large Family-Based Study of Li-Fraumeni SyndromeMegan N Frone, Douglas R Stewart, Sharon A Savage, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2023
Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni SyndromeJessica N Hatton, Kelvin C de Andrade, Megan N Frone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2019
A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of <i>BRCA1/2</i>Ana F Best, Margaret A Tucker, Megan N Frone, et al.
The Journal of Investigative Dermatology|February 20, 2022
Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni SyndromeJessica N Hatton, Michael R Sargen, Megan N Frone, et al.
Journal of the National Cancer Institute|January 23, 2026
Urgent need to recognize that Disease-Causing TP53 variants with atypical penetrance require distinct clinical recommendationsChristian P Kratz, Megan N Frone, Payal P Khincha, et al.
The Lancet. Oncology|November 15, 2021
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort studyKelvin César de Andrade, Payal P Khincha, Jessica N Hatton, et al.
AACE Clinical Case Reports|July 31, 2025
SDHD Gene Mutations: Looking Beyond Head and Neck TumorsSushma Kadiyala, Yasmin Khan, Valeria de Miguel, et al.
American Journal of Medical Genetics. Part A|January 24, 2026
Wide Ranging Neurobehavioral Phenotype in Individuals With Costello SyndromeMillicent S Curlee, Atara Siegel, Paige Little, et al.
Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|December 17, 2019
Stomaching Multigene Panel Testing: What to Do About CDH1?Douglas R Stewart, Megan N Frone, Stephen J Chanock
JCO Precision Oncology|November 22, 2021
Quantification of Discordant Variant Interpretations in a Large Family-Based Study of Li-Fraumeni SyndromeMegan N Frone, Douglas R Stewart, Sharon A Savage, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2023
Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni SyndromeJessica N Hatton, Kelvin C de Andrade, Megan N Frone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2019
A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of <i>BRCA1/2</i>Ana F Best, Margaret A Tucker, Megan N Frone, et al.
The Journal of Investigative Dermatology|February 20, 2022
Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni SyndromeJessica N Hatton, Michael R Sargen, Megan N Frone, et al.
Journal of the National Cancer Institute|January 23, 2026
Urgent need to recognize that Disease-Causing TP53 variants with atypical penetrance require distinct clinical recommendationsChristian P Kratz, Megan N Frone, Payal P Khincha, et al.
The Lancet. Oncology|November 15, 2021
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort studyKelvin César de Andrade, Payal P Khincha, Jessica N Hatton, et al.
AACE Clinical Case Reports|July 31, 2025
SDHD Gene Mutations: Looking Beyond Head and Neck TumorsSushma Kadiyala, Yasmin Khan, Valeria de Miguel, et al.
American Journal of Medical Genetics. Part A|January 24, 2026
Wide Ranging Neurobehavioral Phenotype in Individuals With Costello SyndromeMillicent S Curlee, Atara Siegel, Paige Little, et al.
Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.
Pageof 3